Litigation Details for United States Gypsum Company v. New NGC, Inc. (D. Del. 2017)
✉ Email this page to a colleague
United States Gypsum Company v. New NGC, Inc. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-02-05 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 10,030,060 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in United States Gypsum Company v. New NGC, Inc.
Details for United States Gypsum Company v. New NGC, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-09-05 | 114 | ('284 patent, col. 4:3-10; 30:60-67) However, the specification of the '284 patent defines enhancing…284 patent. The '550 patent has the same disclosure as the '284 patent. ('550 patent, col…236 patent, claim 2; '914 patent, claim 1; '034 patent, claims 1, 9; '904 patent, claims…States Patent Nos. 6,342,284 ("the '284 patent"); 6,632,550 ("the '550 patent"… 54, 55; '236 patent, claim 2; '980 patent, claims 1, 6, 7; '914 patent, claim 1; '034 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |